
Pulse Biosciences PLSE
$ 24.55
-9.41%
Quarterly report 2026-Q1
added 05-14-2026
Country |
|
IPO year |
2016 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
67.4 M |
Market Cap[1] |
$ 1.65 B |
EBITDA (LTM) |
$ -77.4 M |
P/E (LTM) |
-24.86 |
P/S (LTM) |
1527.1 |
EPS (LTM) |
-1.09 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
$ 59.61 | -1.28 % | $ 11.9 B | NYSE,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 114.0 | -0.14 % | $ 3.65 B | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
ICU Medical
ICUI
|
$ 118.72 | -3.47 % | $ 2.93 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.9 | -2.01 % | $ 180 M | Nasdaq Capital Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Intuitive Surgical
ISRG
|
$ 421.12 | -1.62 % | $ 150 B | Nasdaq Global Select Market,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 97.31 | -2.2 % | $ 2.2 B | Nasdaq Global Market,SPB | ||
|
Alcon
ALC
|
$ 63.64 | -0.56 % | $ 40.4 B | NYSE | ||
|
Masimo Corporation
MASI
|
$ 178.47 | 0.07 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Envista Holdings Corporation
NVST
|
$ 23.22 | -2.68 % | $ 3.9 B | NYSE | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
electroCore
ECOR
|
$ 6.27 | -2.49 % | $ 53.2 K | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 56.29 | -1.4 % | $ 2.83 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 32.07 | 0.19 % | $ 1.59 B | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 212.11 | -1.79 % | $ 20.9 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 129.71 | -0.44 % | $ 5.79 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 144.01 | 1.31 % | $ 6.97 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.77 | 1.86 % | $ 181 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 1.85 | - | $ 84.7 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.33 | -2.62 % | $ 27.1 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 61.36 | -1.92 % | $ 3.63 B | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 63.34 | -0.57 % | $ 205 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 302.89 | 0.9 % | $ 21.9 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.07 | -3.27 % | $ 2.01 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.64 | -7.25 % | $ 19.2 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 59.27 | 1.06 % | $ 195 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 20.76 | -1.42 % | $ 991 M | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.85 | -4.64 % | $ 168 M | NYSE American | ||
|
Baxter International
BAX
|
$ 17.3 | -2.7 % | $ 8.87 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 201.88 | -0.29 % | $ 29.5 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 28.12 | -0.11 % | $ 1.34 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.25 | -4.89 % | $ 233 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 10.77 | -2.36 % | $ 440 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 143.47 | -0.69 % | $ 41.3 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.13 | -6.29 % | $ 33.2 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.0 | 1.69 % | $ 220 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 102.87 | -0.49 % | $ 5.78 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.